6th Edition: Trends in Marketing Communications Law Cannabidiol (CBD) appears to be everywhere lately — available as an additive in certain food and drink products, as an oil meant to be used as a dietary supplement and even in cosmetics. But despite the widespread popularity and excitement over Continue Reading
The FTC’s “Reasonable Basis” Standard Has Evolved for Disease Efficacy Claims
The Bottom Line The FTC made it clear many times in 2018 that disease efficacy claims must be supported by competent and reliable scientific evidence, including human clinical testing, and that expert opinions will help guide the kind of human clinical testing and the number of RCTs that is Continue Reading
Regulatory and Class Action Claims Against “Healthy” and “Natural” Food and Dietary Supplement Products on the Rise
5th Edition: Trends in Marketing Communications Law The U.S. Food and Drug Administration (FDA) and class action bar are continuing to pursue enforcement and litigation against food and dietary supplement manufacturers who make drug claims, and in 2017, paid particular attention to products Continue Reading
FTC Renews Focus On Efficacy And Safety Claims
4th Edition: Trends in Marketing Communications Law The Federal Trade Commission (FTC) has increased its enforcement efforts against marketers for failing to substantiate their efficacy and safety claims with competent and reliable evidence. When evaluating claims about the efficacy and safety Continue Reading